• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Omnes Capital

IDI to buy minority stake in Omnes
IDI to buy minority stake in Omnes

Further details are expected to be announced in the coming six weeks, according to a statement

  • GPs
  • 27 January 2022
Omnes closes Capenergie 4 on €660m
Omnes closes Capenergie 4 on €660m

Fund exceeds its €500m target and initial €600m hard-cap, having launched in late 2019

  • Funds
  • 25 May 2021
Omnes buys minority stake in Tennaxia
Omnes buys minority stake in Tennaxia

Company will use investment to step up cross-selling strategy, strengthen sales teams, and attract new customers

  • Buyouts
  • 17 December 2020
BPI France, Omnes lead €12m series-A for AlgoTherapeutix
BPI France, Omnes lead €12m series-A for AlgoTherapeutix

Company intends to use the proceeds to finance the clinical development of its lead candidate ATX01

  • Early-stage
  • 24 November 2020
Omnes, BPI France sell Somos to trade
Omnes, BPI France sell Somos to trade

Semiconductor company has been acquired by Switzerland-based ST Microelectronics

  • Exits
  • 16 October 2020
Omnes hits fundraising trail for Croissance 5 fund
Omnes hits fundraising trail for Croissance 5 fund

French firm looks to raise €350m for its fifth mid-cap buyout and growth capital vehicle

  • Funds
  • 09 October 2020
Omnes, Alliance Entreprendre inject €10m into Sekoia
Omnes, Alliance Entreprendre inject €10m into Sekoia

Cybersecurity company had been self-financed for the past 10 years

  • Expansion
  • 09 October 2020
France Fundraising Pipeline - Q4 2020
France Fundraising Pipeline - Q4 2020

Unquote rounds up the most notable fundraises currently ongoing in the French market across the buyout, venture and secondaries spaces

  • France
  • 08 October 2020
AB Tasty raises $40m from Crédit Mutuel Innovation et al.
AB Tasty raises $40m from Crédit Mutuel Innovation et al.

AB Tasty has raised $64m to date, with Omnes, Partech and Korelya backing a $17m series-B in 2017

  • Expansion
  • 23 July 2020
Omnes, Principia, Seventure in €46.3m series-E for Enterome
Omnes, Principia, Seventure in €46.3m series-E for Enterome

New investors SymBiosis and Takeda Pharmaceutical Company also take part in the round

  • Early-stage
  • 26 June 2020
Omnes announces eight appointments in Paris
Omnes announces eight appointments in Paris

French GP has made appointments across various divisions

  • GPs
  • 23 June 2020
Omnes invests €60m in Biofutur's MBO
Omnes invests €60m in Biofutur's MBO

GP invests in the company via Omnes Croissance 4 and a co-investment vehicle dedicated to the deal

  • Buyouts
  • 21 May 2020
Omnes holds first close for Capenergie 4 on €380m
Omnes holds first close for Capenergie 4 on €380m

Fund completed its first deal, backing Denmark-based solar energy provider Better Energy

  • Funds
  • 23 January 2020
Omnes backs Opportunity LBO
Omnes backs Opportunity LBO

MACSF co-invested with the GP in a spin-off from Vocalcom Group, an Apax France portfolio company

  • Buyouts
  • 20 January 2020
Idinvest exits Bimedia to trade in €50m deal
Idinvest exits Bimedia to trade in €50m deal

Deal ends a four-year holding period for Idinvest Partners, which backed the company alongside Omnes

  • Exits
  • 25 November 2019
Consortium backs €38.75m series-B for Tissium
Consortium backs €38.75m series-B for Tissium

France-based wound dressing developer previously raised €30.5m at the series-A stage

  • Expansion
  • 20 November 2019
Pechel, Ommes back Jems Group MBO
Pechel, Ommes back Jems Group MBO

Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm

  • Buyouts
  • 13 November 2019
Omnes in talks to buy BioFutur
Omnes in talks to buy BioFutur

GP is aiming to acquire a majority stake in the French medical and biology analysis company

  • Buyouts
  • 08 November 2019
Omnes-backed Batiweb buys Archionline
Omnes-backed Batiweb buys Archionline

Batiweb buys Archionline with the help of €6m in mezzanine debt raised from Idinvest

  • Portfolio management
  • 26 September 2019
Omnes leads €8.4m funding round for Newronika
Omnes leads €8.4m funding round for Newronika

Previous backers Indaco Venture Partners and Innogest also take part in the round alongside F3F

  • Early-stage
  • 26 September 2019
Andera, Omnes buy majority stake in Spherea
Andera, Omnes buy majority stake in Spherea

Company management and existing shareholders Ace and Irdi-Soridec Gestion reinvest in the business

  • Buyouts
  • 16 May 2019
LeadX Capital leads $20.4m series-B for 360Imprimir
LeadX Capital leads $20.4m series-B for 360Imprimir

Omnes Capital, Pathena and Fundo 200M (managed by PME Investimentos) also take part in the round

  • Expansion
  • 10 May 2019
Omnes et al. back Camerus, which bolts on Lign'Expo
Omnes et al. back Camerus, which bolts on Lign'Expo

Furniture rental company Camerus's buyout coincides with the bolt-on of domestic peer Lign'Expo

  • Buyouts
  • 10 May 2019
BPI leads €13m series-A for NH TherAguix
BPI leads €13m series-A for NH TherAguix

Omnes Capital, BPI France and investment management firm Arbevel are new investors

  • Early-stage
  • 11 April 2019
123
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013